Compare Marvell Technology Inc (MRVL) vs Smith & Nephew plc (SNN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Marvell Technology Inc vs Smith & Nephew plc — how do they compare? Marvell Technology Inc trades at $232.25 (market cap $200.91B), while Smith & Nephew plc trades at $27.67 (market cap $11.63B). The key difference: Marvell Technology Inc is far larger — about 17.3× Smith & Nephew plc's market cap, and Smith & Nephew plc pays the higher dividend (2.85%). Which is the better fit depends on your goals.
| MRVL | SNN | |
|---|---|---|
Market Cap | $200.91B | $11.63B |
Sector | Technology | Health |
52-Week High | $316.43 | $38.53 |
52-Week Low | $66.59 | $27.80 |
Enterprise Value | $202.26B | $14.66B |
Dividend Yield | 0.11% | 2.85% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Marvell Technology (MRVL) trades at $225.41, up 0.83% with strong technical momentum and bullish moving average signals. The company demonstrates robust revenue growth with Q2 2026 EPS beating expectations at $0.94 versus $0.934, while management projects revenue reaching $12 billion this fiscal year and $18 billion next year. Analyst consensus remains overwhelmingly positive with 82% buy ratings and a $303.11 price target, representing 35% upside potential from current levels.
Marvell's AI-driven growth trajectory presents significant opportunity, though investors face risks from high valuation multiples (P/E 74.02) and competitive pressures in the semiconductor space. The stock's recent 31% pullback from yearly highs offers potential entry point for growth-oriented investors, supported by strong institutional accumulation and positive earnings momentum heading into October's Investor Day event.
Smith & Nephew (SNN) trades at $27.87, down 3.46% over 24 hours and near its 52-week low. The stock shows a bearish technical trend with mixed sentiment; recent earnings have mostly beaten expectations, but Q2 2026 revenue growth missed and guidance was cut. Fundamentals are solid with revenue rising to $6.16B in 2025 and net income margin improving to 10.08%, though debt levels have increased. The company faces competitive pressures in key markets like U.S. Orthopaedics.
Outlook is cautious: valuation ratios like P/E of 18.96 are reasonable, but analyst consensus is Hold (65%) due to execution risks and CFO departure. Opportunities include innovation in surgical robotics and new product launches, but investors should monitor U.S. market weakness and debt management for sustained recovery.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Marvell Technology Inc
Marvell Technology is a leading fabless chipmaker focused on networking and storage applications. Marvell serves the data center, carrier, enterprise, automotive, and consumer end markets with processors, optical interconnections, application-specific integrated circuits (ASICs), and merchant silicon for Ethernet applications. The firm is an active acquirer, with five large acquisitions since 2017 helping it pivot out of legacy consumer applications to focus on the cloud and 5G markets.
Read more on MRVL →About Smith & Nephew plc
Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound-care solutions. Roughly 42% of the U.K.-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 28% of revenue is from the advanced wound therapy segment. Roughly half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.
Read more on SNN →
